Skip to content

The effect and mechanism of high-Intensity transcranial alternating current stimulation on cognitive improvement in patients with Treatment-Resistant Schizophrenia

The effect and mechanism of high-Intensity transcranial alternating current stimulation on cognitive improvement in patients with Treatment-Resistant Schizophrenia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124872
Enrollment
Unknown
Registered
2026-05-18
Start date
2025-06-29
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment-Resistant Schizophrenia

Interventions

sham stimulation group:sham stimulation
active stimulation group:high-Intensity transcranial alternating current stimulation (HI-tACs)

Sponsors

Tianjin Anding Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Han Chinese; 2. 18-65 years old; 3. Meeting the diagnostic criteria for schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); 4. Having received at least two antipsychotic medications with different mechanisms of action at adequate doses and for sufficient durations, and currently on a stable dose of clozapine monotherapy (at least 400 mg/day or higher for a minimum of 6 months) to ensure a reasonable response to clozapine; 5.A review of the patient's medical history indicates persistent psychotic symptoms that have not been effectively controlled; 6. The patient and/or their legal guardian must provide written informed consent and agree to participate voluntarily.

Exclusion criteria

Exclusion criteria: 1. Meeting DSM-5 diagnostic criteria for other mental disorders; 2. Patients with severe physical illnesses, including cardiovascular, cerebrovascular, or pulmonary diseases, epilepsy; 3. Presence of substance and/or alcohol abuse; 4. Contraindications to electrical stimulation, such as: metallic objects or implants in the head or scalp, implanted cardiac pacemakers, skull defects or fractures, allergy to stimulation materials; 5. Women who are pregnant, in the perinatal period, or lactating; 6. Having received other brain stimulation therapies (TMS, tDCS, MECT, etc.) within the past month;

Design outcomes

Primary

MeasureTime frame
Cognition;Schizophrenia positive and negative symptoms;Schizophrenia negative symptoms;

Secondary

MeasureTime frame
Alexithymia Indicator;Dietary characteristics;Abnormal Involuntary;sleep quality;Dimensional Anhedonia;Depression symptoms;Psychological Function Indicator;Global assessment function;Brain Function Index;anxiety symptoms;Brain Function Index;Brain Function Index;Loneliness Indicator;Interpersonal reactions and expressions;Extrapyramidal side effects;Dietary characteristics;

Countries

China

Contacts

Public ContactLi Shen

Tianjin Anding Hospital

lishen@tmu.edu.cn+86 22 8818 8875

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026